The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.

Michael Saylor's Strategy now holds 528,185 Bitcoin worth around $35.63 billion. The company is the world's largest corporate ...

The stock market—and biotech insiders—reacted negatively to the allegedly forced resignation of CBER Director Peter Marks, ...

BMO Capital Markets analysts said the results potentially position lepodisiran as “one of the most durable assets in ...

Small and mid-cap stocks that are high quality have growth-at-a-reasonable price characteristics may present opportunities ...

The value of global syndicated lending declined in the first quarter, according to new data from LSEG Data & Analytics. The ...

BMO Capital analyst Katja Jancic downgraded U.S. Steel (X) to Market Perform from Outperform with an unchanged price target of $45. The current ...

BMO Capital Markets upgraded shares of Check Point Software Technologies (NASDAQ:CHKP – Free Report) from a market perform rating to an outperform rating in a research report released on Friday ...

BMO Capital analysts view the departure of Dr. Peter Marks from the FDA as a “significant negative” for the biopharma and biotech sectors. The ...

BMO Capital Markets upgraded Check Point Software Technologies (NASDAQ:CHKP) Ltd to Outperform from Market Perform, citing increased confidence in the company’s growth trajectory and a reasonable ...

The company, which has the second-largest bitcoin stash among publicly-traded companies, could use the funds to finance ...

Lululemon Athletica (NASDAQ:LULU – Get Free Report) had its price target lowered by stock analysts at BMO Capital Markets from $313.00 to $302.00 in a research report issued on Friday ...